Dan Bloomfield, MD, chief medical officer, Anthos, walks through promising findings demonstrating the efficacy of abelacimab, ...

Miriam Stoppard shares research from University College London that could bring peace of mind to patients with heart rhythm ...

The FDA is elevating a recall from Boston Scientific covering its cryoablation balloon catheters for the treatment of atrial ...

In patients with atrial fibrillation, a resting heart rate of 80 bpm or higher is associated with increased risk for mortality.

That’s not the case for all of us, I’m reminded, as I look inside a cardboard box containing around 20 plastic hearts—each a ...

Pulsed field ablation (PFA), which uses shorts bursts of high energy to neutralize abnormal heart tissue, was approved by the ...

Erlanger Cardiology completed the first in Chattanooga concomitant left atrial appendage closure (LAAC) and cardiac ablation ...

During a Case-Based Roundtable® event, Daniel A. Ermann, MD, discussed evaluation and treatment for a patient with relapsed ...

A combination of Imbruvica and venetoclax showed significantly prolonged progression-free survival in patients with untreated ...

The first-in-human trial is taking place at Na Homolce hospital in Prague, Czech Republic, and will treat up to 50 patients.

The China 3D cardiac mapping market has showcased significant growth, with its valuation increasing from $55.55 million in 2019 to a projected $150.59 million by 2027. This report offers a detailed ...

In the U.S., atrial fibrillation (AF), a heart condition that causes an irregular heartbeat in the upper chambers of the ...